Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Alcohol Alcohol ; 47(3): 273-81, 2012.
Article in English | MEDLINE | ID: mdl-22414922

ABSTRACT

AIMS: A number of screening instruments are routinely used in Emergency Department (ED) situations to identify alcohol-use disorders (AUD). We wished to study the psychometric features, particularly concerning optimal thresholds scores (TSs), of four assessment scales frequently used to screen for abuse and/or dependence, the cut-down annoyed guilty eye-opener (CAGE), Rapid Alcohol Problem Screen 4 (RAPS4), RAPS4-quantity-frequency and AUD Identification Test (AUDIT) questionnaires, particularly in the sub-group of people admitted for acute alcohol intoxication (AAI). METHODS: All included patients [AAI admitted to ED (blood alcohol level ≥0.8 g/l)] were assessed by the four scales, and with a gold standard (alcohol dependence/abuse section of the Mini International Neuropsychiatric Interview), to determine AUD status. To investigate the TSs of the scales, we used Youden's index, efficiency, receiver operating characteristic (ROC) curve techniques and quality ROC curve technique for optimized TS (indices of quality). RESULTS: A total of 164 persons (122 males, 42 females) were included in the study. Nineteen (11.60%) were identified as alcohol abusers alone and 128 (78.1%) as alcohol dependents (DSM-IV). Results suggest a statistically significant difference between men and women (P < 0.05) in performance of the screening tests RAPS4 (≥1) and CAGE (≥2) for detecting abuse. Also, in this population, we show an increase in TSs of RAPS4 (≥2) and CAGE (≥3) for detecting dependence compared with those typically accepted in non-intoxicated individuals. The AUDIT test demonstrates good performance for detecting alcohol abuse and/or alcohol-dependent patients (≥7 for women and ≥12 for men) and for distinguishing alcohol dependence (≥11 for women and ≥14 for men) from other conditions. CONCLUSION: Our study underscores for the first time the need to adapt, taking into account gender, the thresholds of tests typically used for detection of abuse and dependence in this population.


Subject(s)
Alcoholic Intoxication , Alcoholism/diagnosis , Mass Screening/methods , Adult , Emergency Service, Hospital , Female , Humans , Male , Middle Aged , Psychometrics/instrumentation , ROC Curve , Sensitivity and Specificity , Sex Factors , Surveys and Questionnaires
2.
J Thromb Haemost ; 9(3): 464-72, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21232002

ABSTRACT

BACKGROUND: Unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are both recommended for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients. OBJECTIVE: To perform an individual patient data meta-analysis to evaluate the relative efficacy and safety of the LMWH enoxaparin and UFH in preventing VTE in hospitalized medical patients. METHODS: Randomized clinical trials comparing subcutaneous enoxaparin (4000 IU once-daily) and UFH (5000 IU subcutaneous two- or three-times daily) for VTE prevention were identified by a systematic search. Individual patient data were obtained from each eligible trial. RESULTS: Overall, four trials were eligible, including 3600 patients randomized to receive enoxaparin (n = 1799) or UFH (n = 1801). Median patient age was 71 years, and 49.3% were female. Compared with UFH, enoxaparin was associated with risk reductions of 37% for total VTE [relative risk (RR) 0.63, 95% confidence interval (CI) 0.51-0.77] and 62% for symptomatic VTE (RR 0.38, 95% CI 0.17-0.85) at day 15. RR for total VTE in stroke and non-stroke patients was 0.59 (95% CI 0.47-0.74) and 0.87 (95% CI 0.51-1.50), respectively. Major bleeding rates were consistently low and similar between treatment groups at day 15 (RR 1.13, 95% CI 0.53-2.44). There was a trend towards reduced risk for mortality in patients receiving enoxaparin (RR 0.83, 95% CI 0.64-1.08), compared with UFH. CONCLUSIONS: Enoxaparin significantly reduces VTE in hospitalized medical patients, compared with UFH, without increasing the risk for major bleeding, and was associated with a trend towards reduced all-cause mortality.


Subject(s)
Anticoagulants/pharmacology , Enoxaparin/pharmacology , Heparin/pharmacology , Venous Thromboembolism/prevention & control , Aged , Anticoagulants/administration & dosage , Anticoagulants/adverse effects , Double-Blind Method , Enoxaparin/administration & dosage , Enoxaparin/adverse effects , Female , France/epidemiology , Hemorrhage/etiology , Heparin/administration & dosage , Heparin/adverse effects , Humans , Male , Middle Aged , Randomized Controlled Trials as Topic , Risk Factors , Treatment Outcome , Venous Thromboembolism/mortality
3.
Nephrol Ther ; 5(2): 150-6, 2009 Apr.
Article in French | MEDLINE | ID: mdl-18514053

ABSTRACT

The hepatorenal syndrome (HRS) is an acute functional renal failure due to renal arterial vasoconstriction occurring in cirrhotic patients with vascular dysfunction. The renal arterial vasoconstriction is the result of diffuse arteriole vasodilatation. There are two types of HRS, which can be differentiated according to the course and the stage of the renal failure; they have a different prognosis. Liver transplantation remains the standard treatment. Maintenance medical therapy is mainly based on vasopressin analogues. The interest of both dialysis and portosystemic intrahepatic shunt techniques remains to be determined. The prognosis of HRS is poor and in the absence of treatment, onset is usually followed by rapid fatal outcome.


Subject(s)
Hepatorenal Syndrome , Combined Modality Therapy , Hepatorenal Syndrome/diagnosis , Hepatorenal Syndrome/physiopathology , Hepatorenal Syndrome/therapy , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/physiopathology , Liver Cirrhosis/surgery , Liver Transplantation , Models, Biological , Prognosis , Renal Replacement Therapy , Vasoconstriction , Vasodilator Agents/therapeutic use , Vasopressins/therapeutic use
4.
Presse Med ; 33(5): 318-20, 2004 Mar 13.
Article in French | MEDLINE | ID: mdl-15041878

ABSTRACT

BACKGROUND: Actinomycosis is a subacute or chronic bacterial infection, which can affect immunocompetent or immunodeficient subjects. It most often occurs in cervico-facial or thoracic-abdominal locations. Central nervous system infection is rare but of severe prognosis. CASE REPORT: A 56 year-old woman with no history of immunodepression was admitted with unexplained fever, inappropriate behaviour, and spatial and temporal disorientation. The progressive worsening of the neurological signs let to coma and mechanical ventilation was required. Brain imaging showed multilocation cerebral abscesses. Stereotaxial biopsy permitted diagnosis of actinomycosis. Patient's outcome was favourable following appropriate dual antibiotherapy without surgical exeresis. DISCUSSION: When lacking bacteriologic identification, diagnosis of cerebral actinomycosis is performed by pathologic findings. Dual antibiotherapy allows full recover, even in the case of multilocation cerebral abscesses.


Subject(s)
Actinomycosis/diagnosis , Brain Abscess/diagnosis , Actinomyces/isolation & purification , Actinomycosis/drug therapy , Actinomycosis/pathology , Acyclovir/administration & dosage , Acyclovir/therapeutic use , Amoxicillin/administration & dosage , Amoxicillin/therapeutic use , Biopsy , Brain Abscess/drug therapy , Brain Abscess/microbiology , Brain Abscess/pathology , Chloramphenicol/administration & dosage , Chloramphenicol/therapeutic use , Clindamycin/administration & dosage , Clindamycin/therapeutic use , Coma/etiology , Diagnostic Errors , Drug Therapy, Combination/therapeutic use , Encephalitis, Herpes Simplex/diagnosis , Female , Fever/etiology , Humans , Listeriosis/diagnosis , Magnetic Resonance Imaging , Meningoencephalitis/diagnosis , Middle Aged , Nocardia Infections/diagnosis , Remission Induction , Tuberculosis, Meningeal/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...